Literature DB >> 9262393

Immunotherapy. Fusion induces tumour rejection.

I Hart, C Colaco.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9262393     DOI: 10.1038/41662

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.

Authors:  Jin-Kun Zhang; Jun Li; Juan Zhang; Hai-Bin Chen; Su-Biao Chen
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

3.  Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.

Authors:  D J Dunnion; A L Cywinski; V C Tucker; A K Murray; A B Rickinson; P Coulie; M J Browning
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

4.  Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

Authors:  Maria R Parkhurst; Cormac DePan; John P Riley; Steven A Rosenberg; Suyu Shu
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

5.  In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells.

Authors:  Feng Xu; Ying-Jiang Ye; Shan Wang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

6.  Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells.

Authors:  Weidong Zhang; Hong Yang; Hongtao Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.